Fredrick Wigley is a Rheumatology/Immunology physician affiliated with Johns Hopkins University. OpenAlex indexes 359 publications with 25,342 citations (h-index 83); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- High Dose Cyclophosphamide for Treatment of Scleroderma
Sponsor: Johns Hopkins University
- A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon
Sponsor: Johns Hopkins University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
36.2%Calcium channel blocker17.2%Amlodipine Besylate82%Nifedipine Er18%Part D<11 patientsAngiotensin receptor blocker (ARB)3.8%Losartan Potassium100%Part D≥13 patients+ 8 more classes in this area
Metabolism & gastrointestinal
26.8%Proton pump inhibitor13.5%Omeprazole46%Pantoprazole Sodium36%Esomeprazole Magnesium18%Part D<11 patientsH2 blocker8.9%Famotidine100%Part D≥34 patients+ 2 more classes in this area
Nervous system
20.7%SSRI5.2%Sertraline Hcl58%Trazodone Hcl22%Paroxetine Hcl20%Part D<11 patientsGabapentinoids4.7%Gabapentin100%Part D≥18 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 1992–2016 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”